Main about DrugCard
- DrugCard is a platform for automatic monitoring of medical literature. The product helps pharmaceutical companies reduce costs, streamline routine processes, and ensure pharmacovigilance regulations.
- The startup collects information from medical and scientific sources, analyzes and issues it to specialists, thus facilitating the routine work of pharmacovigilance specialists.
- Most of the money will be spent on marketing, promotion and entering the European market.
The company has three founders and five specialists. DrugCard started its work in 2020 and came out to the market in the spring of 2021.
About the investment round
Lead investors are Spain venture capital firm Think Bigger Capital and Ukrainian Farmak
Farmak — is a Ukrainian manufacturer of medicines of the European level. Thanks to quality and innovation, Farmak has been a leader in the Ukrainian pharmaceutical market since 2010 and is a powerful exporter of medicines.
Think Bigger Capital — is a tech and innovation venture capital firm based in Spain investing in talent, pre-seed and seed stages.
